Cargando…

Sirolimus (Rapamycin) Induced Mucosal Healing in Anti-Tumor Necrosis Factor Refractory Pediatric Ulcerative Colitis

Sirolimus (rapamycin) has been sparsely reported in the treatment of pediatric ulcerative colitis (PUC). Mucosal healing has not been examined in responders to the drug. We describe a case of infliximab refractory PUC where rapamycin induced sustained clinical remission along with mucosal healing. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kellermayer, Richard, Chang, Andrew, Patel, Kalyani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins, Inc. 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158451/ https://www.ncbi.nlm.nih.gov/pubmed/37168909 http://dx.doi.org/10.1097/PG9.0000000000000183

Ejemplares similares

Mucosal healing in ulcerative colitis: surveillance or colectomy?
por: Andrisani, Gianluca, et al.
Publicado: (2013)

Relationship between mucosal healing by tacrolimus and relapse of refractory ulcerative colitis: a retrospective study
por: Ito, Ayumi, et al.
Publicado: (2020)

Novel oral-targeted therapies for mucosal healing in ulcerative colitis
por: Antonelli, Elisabetta, et al.
Publicado: (2018)

Topical rapamycin (sirolimus) for facial angiofibromas
por: Madke, Bhushan
Publicado: (2013)

DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis
por: Harris, R Alan, et al.
Publicado: (2014)

Narrow band imaging efficiency in evaluation of mucosal healing/relapse of ulcerative colitis
por: Sasanuma, Seiko, et al.
Publicado: (2018)

Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis
por: Chen, Fang, et al.
Publicado: (2021)

Artificial intelligence‐assisted endoscopy changes the definition of mucosal healing in ulcerative colitis
por: Nakase, Hiroshi, et al.
Publicado: (2020)

Gelsolin as a Potential Biomarker for Endoscopic Activity and Mucosal Healing in Ulcerative Colitis
por: Maeda, Keiko, et al.
Publicado: (2022)

Endoscopy for assessment of mucosal healing in ulcerative colitis: time bound or response guided?
por: Sood, Ajit, et al.
Publicado: (2022)

Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis
por: Yokoyama, Kaoru, et al.
Publicado: (2013)

An Elevated Platelet Count Increases the Risk of Relapse in Ulcerative Colitis Patients with Mucosal Healing
por: Nakarai, Asuka, et al.
Publicado: (2018)

Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis
por: Matusiewicz, Malgorzata, et al.
Publicado: (2017)

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
por: Szymańska, Edyta, et al.
Publicado: (2020)

Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series
por: Bekheit, Mohamed, et al.
Publicado: (2016)

Anterior Gradient Protein 2 Promotes Mucosal Repair in Pediatric Ulcerative Colitis
por: Ye, Xiaolin, et al.
Publicado: (2021)

A Single-Center Study of Long-Term Effectiveness of Vedolizumab in Anti-TNF Refractory Pediatric Inflammatory Bowel Disease
por: Patel, Halee, et al.
Publicado: (2022)

The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing
por: Yoshino, Takuya, et al.
Publicado: (2016)

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis
por: Shinzaki, Shinichiro, et al.
Publicado: (2017)

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis
por: Kristensen, Vendel, et al.
Publicado: (2017)

Long‐Chain Polyphosphate Is a Potential Agent for Inducing Mucosal Healing of the Colon in Ulcerative Colitis
por: Fujiya, Mikihiro, et al.
Publicado: (2019)

The inverse association between unhealthy eating habit and mucosal healing among patients with ulcerative colitis
por: Furukawa, Shinya, et al.
Publicado: (2021)

Effect of disease duration on the association between serum albumin and mucosal healing in patients with ulcerative colitis
por: Yagi, Sen, et al.
Publicado: (2021)

Association Between Peripheral Blood Monocyte Count and Mucosal Healing in Japanese Patients With Ulcerative Colitis
por: Furukawa, Shinya, et al.
Publicado: (2021)

Usefulness of Examining Various Patient-Reported Outcomes in Predicting Endoscopic Mucosal Healing in Ulcerative Colitis
por: Min Moon, Jung, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing
por: Kurimoto, Noriyuki, et al.
Publicado: (2023)

Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis
por: Parkes, Gareth, et al.
Publicado: (2023)

Retrospective investigation of tacrolimus combined with an anti‐tumor necrosis factorα antibody as remission induction therapy for refractory ulcerative colitis: Efficacy, safety, and relapse rate
por: Ito, Ayumi, et al.
Publicado: (2019)

Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
por: Berends, Sophie E., et al.
Publicado: (2019)

Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy
por: Baird, Angela C, et al.
Publicado: (2016)

Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use
por: Kang, Ho Suk, et al.
Publicado: (2019)

Lesson from Real-World Experience: Optimal Treatment with Anti-Tumor Necrosis Factor for Ulcerative Colitis
por: Chun, Jaeyoung
Publicado: (2021)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

Gut mucosal virome alterations in ulcerative colitis
por: Zuo, Tao, et al.
Publicado: (2019)

Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients
por: Kitayama, Moto, et al.
Publicado: (2020)

Raman spectroscopy of endoscopic colonic biopsies from patients with ulcerative colitis to identify mucosal inflammation and healing
por: Addis, James, et al.
Publicado: (2016)

Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Prostaglandin E‐major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase
por: Sakurai, Toshiyuki, et al.
Publicado: (2022)

Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
por: Lee, Sun-Ho, et al.
Publicado: (2017)

Tumor Necrosis Factor Alpha Blocking Agents as Treatment for Ulcerative Colitis Intolerant or Refractory to Conventional Medical Therapy: A Meta-Analysis
por: Lv, Ruxi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rs9jp0c9k6g5vvaur7rg6blird